PDT
Sponsors
Ishiwatari Hirotoshi, Photocure, Peking University People's Hospital, University of Nove de Julho, First People's Hospital of Hangzhou
Conditions
AcneAcne VulgarisAge-related Macular DegenerationBasal Cell CarcinomaBile Duct CancerCentral Serous ChorioretinopathyCholangiocarcinomaDiabetic Foot Infection
Phase 2
Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)
CompletedNCT00933543
Start: 2009-08-31End: 2010-03-31Updated: 2013-12-11
Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy
RecruitingNCT05020912
Start: 2021-12-13End: 2027-12-31Target: 28Updated: 2025-11-26
Phase1/2 study of endoscopic photodynamic therapy using ME2906 and ultrathin PDT probe in unresectable bile duct cancer
RecruitingJPRN-jRCT2041220118
Start: 2023-02-03Target: 53Updated: 2025-07-18
Phase 4
Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC)
CompletedNCT01574430
Start: 2010-12-31End: 2014-12-31Target: 131Updated: 2016-08-16
Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose
NCT02864472
Start: 2016-09-30End: 2019-01-31Target: 40Updated: 2016-08-12
Unknown Phase
Photodynamic Therapy in Adolescents Halitosis
NCT02007993
Start: 2013-11-30End: 2014-10-31Target: 130Updated: 2014-08-04
Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma
CompletedNCT02585856
Start: 2013-02-28End: 2018-08-31Updated: 2018-12-19
A Clinical Trial Testing the Efficacy of PDT in Preventing Amputation in Diabetic Patients
CompletedNCT03380403
Start: 2010-01-01End: 2012-01-01Updated: 2017-12-28
St. John's Wort Photodynamic Therapy
CompletedNCT05073211
Start: 2020-06-01End: 2021-09-01Updated: 2021-10-11
A Comparative Study of Endoscopic Submucosal Dissection and Photodynamic Therapy for Early Esophageal Cancer
NCT05208775
Start: 2022-03-01End: 2024-12-30Target: 46Updated: 2022-01-26
Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma
RecruitingNCT05519319
Start: 2023-01-01End: 2026-06-01Target: 70Updated: 2023-02-21